Pharmaceuticals

CVS Health Survey Shows Mental Health Concerns Continue to Rise Post-Pandemic

bexib
By bexib 0 Min Read

Respondents said they were more likely to be concerned about their own or others’ mental health in 2022 and beyond.

You Might Also Like

McMaster University Drug Trial Awards More Than $6 Million to Test Smallpox Vaccine MPOX

The road to Autobahn’s breakthrough depression treatment is paved by a big-name investor

Trial investigating fecal microbiota transplantation to treat rare liver disease

Prominent gene therapy researcher Jim Wilson leaves University of Pennsylvania

FDA Approves Geron’s Lytero for Treatment of Adults with Low-Risk Myelodysplastic Syndrome

Share This Article
Previous Article BNPL competition helps merchants win
Next Article Grand Ball reaches fundraising goal for brain tumor support
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Toyota Financial Services Three ways to utilize next -generation AI
Banking
HSBC shuts down cross-border payments app
Banking
Fiserv appoints PNC Lions chairman to replace Bisignano
Banking
2025 Blueprint: American-Made Infrastructure
Manufacturing